3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Uveal Melanoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Histiocytic Sarcoma
1
Gastrointestinal Neoplasms
1
Central Nervous System Neoplasms
1
Advanced Solid Tumors
1
Advanced Solid Tumor
1
Interventions
Cyclophosphamide
34
fludarabine
25
fludarabine phosphate
24
Tacrolimus
24
Mycophenolic Acid
23
Whole-Body Irradiation
22
Busulfan
15
Methotrexate
12
Melphalan
12
Granulocyte Colony-Stimulating Factor
12
Antilymphocyte Serum
12
thymoglobulin
11
Cyclosporine
11
Stem Cell Transplantation
10
Filgrastim
10
Rituximab
9
Thiotepa
7
Peripheral Blood Stem Cell Transplantation
7
Nivolumab
7
Dexamethasone
7
trametinib
6
Radiotherapy
6
Mesna
6
Cytarabine
6
Prednisone
5
Calcium Dobesilate
5
Bortezomib
5
Azacitidine
5
Alemtuzumab
5
Voriconazole
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hematologic Neoplasms
×
ulixertinib
×
Clear all
No trials found.